Jan Van Elslande
Overview
Explore the profile of Jan Van Elslande including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
513
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Delanghe J, Van Elslande J, Godefroid M, Speeckaert M, Maenhout T
Horm Mol Biol Clin Investig
. 2024 Sep;
PMID: 39344474
Objectives: The secretion of thyroid stimulating hormone (thyrotropin, TSH), is characterized by a marked circadian rhythm. Plasma or serum TSH values are significantly lower in the afternoon and in the...
2.
Delanghe J, Van Elslande J, Godefroid M, Thieuw Barroso A, De Buyzere M, Maenhout T
Clin Chem Lab Med
. 2024 Sep;
63(3):581-586.
PMID: 39301583
Objectives: Fecal immunochemical tests (FIT) for hemoglobin are currently considered the screening investigation of choice for colorectal cancer and are worldwide recommended. Similarly, fecal calprotectin is a widely used test...
3.
Cockx M, Steels S, Michiels B, Van Elslande J, Vermeersch P, Frans G, et al.
J Appl Lab Med
. 2024 Aug;
9(6):977-989.
PMID: 39114898
Background: The presence of anti-interferon (IFN)-α2 autoantibodies is a strong indicator of severe disease course during viral infections and is observed in autoimmune diseases (e.g., myasthenia gravis). Detection of these...
4.
Dedeene L, Van Elslande J, Dewitte J, Martens G, De Laere E, De Jaeger P, et al.
Clin Chim Acta
. 2024 Jul;
562:119854.
PMID: 38977169
Background And Aims: We aimed to develop an easily deployable artificial intelligence (AI)-driven model for rapid prediction of urine culture test results. Material And Methods: We utilized a training dataset...
5.
Cuypers L, Keyaerts E, Hong S, Gorissen S, Menezes S, Starick M, et al.
Nat Aging
. 2023 May;
3(6):722-733.
PMID: 37217661
Coronavirus Disease 2019 (COVID-19) vaccination has resulted in excellent protection against fatal disease, including in older adults. However, risk factors for post-vaccination fatal COVID-19 are largely unknown. We comprehensively studied...
6.
Frans G, Dillaerts D, Dehaemers T, Van Elslande J, De Leeuw J, Boon L, et al.
Front Immunol
. 2023 Mar;
14:1050037.
PMID: 36895570
Pre-vaccination SARS-CoV-2 infection can boost protection elicited by COVID-19 vaccination and post-vaccination breakthrough SARS-CoV-2 infection can boost existing immunity conferred by COVID-19 vaccination. Such 'hybrid immunity' is effective against SARS-CoV-2...
7.
Bossuyt X, Vulsteke J, Van Elslande J, Boon L, Wuyts G, Willebrords S, et al.
Autoimmun Rev
. 2023 Feb;
22(4):103288.
PMID: 36738952
A high prevalence of antinuclear antibodies (ANA) in COVID-19 has been insinuated, but the nature of the target antigens is poorly understood. We studied ANA by indirect immunofluorescence in 229...
8.
Missault S, De Meyst A, Van Elslande J, Van den Abeele A, Steen E, Van Acker J, et al.
Pathogens
. 2023 Jan;
12(1).
PMID: 36678414
is an established zoonotic agent causing respiratory disease in humans. An infection often remains asymptomatic but can also result in flu-like illness, pneumonia or even multi-organ failure. This paper describes...
9.
Decru B, Van Elslande J, Steels S, Van Pottelbergh G, Godderis L, Van Holm B, et al.
Front Immunol
. 2022 Dec;
13:1098285.
PMID: 36505436
[This corrects the article DOI: 10.3389/fimmu.2022.909910.].
10.
Decru B, Van Elslande J, Steels S, Van Pottelbergh G, Godderis L, Van Holm B, et al.
Front Immunol
. 2022 Jul;
13:909910.
PMID: 35784321
Background: IgG anti-spike (S) antibodies arise after SARS-CoV-2 infection as well as vaccination. Levels of IgG anti-S are linked to neutralizing antibody titers and protection against (re)infection. Methods: We measured...